An EASO position statement on multidisciplinary obesity management in adults

Obesity Facts

Volumn 7, Issue 2, 2014, Pages 96-101

  Yumuk, Volkan ^a   Frühbeck, Gema ^b   Oppert, Jean Michel ^c   Woodward, Euan ^d,f   Toplak, Hermann ^e  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF NAVARRA   (Spain)

^c SORBONNE UNIVERSITÉ   (France)

^d European Association for the Study of Obesity (EASO)   (United Kingdom)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f NONE   (United Kingdom)

Author keywords

Multidisciplinary; Obesity management; OMTF; Statement; Treatment; Weight loss

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS; COGNITIVE THERAPY; COMORBIDITY; DIETARY COMPLIANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FAT MASS; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; WELLBEING; ADULT; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EUROPE; FEMALE; MALE; MEDICAL SOCIETY; CLINICAL TRIAL (TOPIC); DIET; DRUG THERAPY; FINANCE; HEALTH CARE DELIVERY; PRESCRIPTION; SOCIAL ASPECT;

ADULT; BODY COMPOSITION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EUROPE; FEMALE; HUMANS; MALE; OBESITY; SOCIETIES, MEDICAL;

ANTIOBESITY AGENT; TETRAHYDROLIPSTATIN;

EID: 84897117592     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000362191     Document Type: Article

References (19)

1. Frühbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM: Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts 2013; 6: 117-120.
2. Tsigos C, Hainer V, Basdevant A, Finer N, Mathus-Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Yumuk V, Zahorska-Markiewicz B: Criteria for EASO-collaborating centres for obesity management. Obes Facts 2011; 4: 329-333.
3. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus-Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Zahorska-Markiewicz B: Management of obesity in Adults: European Clinical Practice Guidelines. Obes Facts 2008; 1: 106-116.
4. Saris WH: Very low calorie diets and sustained weight loss. Obes Res 2001; 9: 295S-310S.
5. Heymsfield SB, van der Mierlo CA, van der Knaap HC, Heo M, Frier HI: Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003; 27: 537-549.
6. Sharma M: Behavioral interventions for preventing and treating obesity in adults. Obes Rev 2006; 7: 183-200.
7. Jebb SA, Ahern AL, Olson AD, Aston LM, Holzapfel C, Stoll J, Amann-Gassner U, Simpson AE, Fuller NR, Pearson S, Lau NS, Mander AP, Hauner H, Caterson ID: Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011; 137: 1485-1492.
8. Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, Daley A, Aveyard P: Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. Br Med J: 2011; 343:d500.
9. Fuller NR, Colagiuri S, Schofield D, Olson AD, Shrestha R, Holzapfel C, Wolfenstetter SB, Holle R, Ahern AL, Hauner H, Jebb SA, Caterson ID: A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care - an international randomised controlled trial. Int J Obes (Lond) 2013; 37: 828-834.
10. Frühbeck G. Obesity: Screening for the evident in obesity. Nat Rev Endocrinol 2012; 8: 570-572.
11. Hainer V, Toplak H, Mitrakou A: Treatment modalities of obesity: what fits whom? Diabetes Care 2008; 31(suppl 2): S269-S277.
12. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-161.
13. Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L: X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced energy diet: early response to treatment predicts weight maintenance. Diabetes Obes Metab. 2005; 7: 699-708.
14. Witkamp RF: Current and future drug targets in weight management. Pharm Res 2011; 28: 1792-1818.
15. Sjöström L: Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273: 219-234.
16. Fried M, Yumuk V, Oppert JM, Scopinari N, Torres AJ, Weiner R, Yashkov Y, Frühbeck G: IFSO-EC and EASO Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts 2013; 6: 449-468.
17. Fried M, Yumuk V, Oppert JM, Scopinari N, Torres AJ, Weiner R, Yashkov Y, Frühbeck G: IFSO-EC and EASO Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24: 42-55.
18. Sikorski C, Luppa M, Kaiser M, Glaesmer H, Schomerus G, König HH, Riedel-Heller SG: The stigma of obesity in the general public and its implications for public health - a systematic review. BMC Public Health 2011; 11: 661.
19. Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M, on behalf of The Lancet NCD Action Group: Inequalities in non-communicable diseases and effective responses. Lancet 2013; 381: 585-597.